Intravenous Infusions is trading 7.27% down at GHS 0.51, with no clear company-specific catalyst identified. - The last completed session was October 9; the supplied context does not establish an October 12 trade. - The Ghana Stock Exchange announced the company’s October 23 annual general meeting on October 7; no source links the notice to the decline. - Ghana’s composite index rose 0.21% on October 9, so market-wide weakness does not explain the move.